Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study  by Arízaga-Ballesteros, Víctor et al.
International Journal of Infectious Diseases 30 (2015) 27–32Can sTREM-1 predict septic shock & death in late-onset neonatal
sepsis? A pilot study§
Vı´ctor Arı´zaga-Ballesteros a, Mario Rene´ Alcorta-Garcı´a a,
Lizzeth Carolina La´zaro-Martı´nez a, Jesu´s Manuel Ame´zquita-Go´mez a,
Jose´ Manuel Alanı´s-Cajero a, Luis Villela b, Fabiola Castorena-Torres b,
Vı´ctor Javier Lara-Dı´az a,b,*
a Tecnolo´gico de Monterrey, Escuela de Medicina. Programa Multice´ntrico de Residencias Me´dicas, Neonatologı´a
b Tecnolo´gico de Monterrey, Escuela de Medicina, Direccio´n de Investigacio´n e Innovacio´n
A R T I C L E I N F O
Article history:
Received 16 July 2014
Received in revised form 28 October 2014










S U M M A R Y
Background and Objectives: The transmembrane glycoprotein TREM-1 triggers an inﬂammatory response.
Its soluble fraction (sTREM-1) has been shown to have diagnostic accuracy for late-onset neonatal sepsis
(LONS). Until now, the potential of sTREM-1 to predict septic shock and/or death in septic neonates has
not been explored. This study obtained estimates of the incidence and prevalence of septic shock and/or
death in septic neonates for future sample size calculations for conﬁrmatory studies and evaluated the
feasibility of using sTREM-1 as a predictor of septic shock and/or death in neonates with LONS criteria.
Study design: A pilot study with a cross-sectional design was performed from May 1st to October 31st,
2012. The participants were hospitalized neonates who, after three days of life, were diagnosed as having
LONS. Plasma sTREM-1 was quantiﬁed by ELISA. The main outcome measurement was the development
of septic shock and/or death.
Results: Of 71 eligible subjects, nine (12.7%) progressed to septic shock and/or death. In the LONS-Non-
Shock group, the sTREM-1 median and interquartile range (IQR) plasma value were 10 (10 to 70) pg/mL.
In the LONS & Shock/Death group, the values were 567 (260 to 649) pg/mL. These values were
signiﬁcantly different (Mann-Whitney’s U test, p = 0.001).
A ROC curve for a proposed sTREM-1 cut-off value of 300 pg/mL exhibited an area under the curve of
0.884 (95% CI = 0.73 to 1.0; p < 0.0001), with a sensitivity of 0.78 (95% CI = 0.46 to 0.94) and speciﬁcity of
0.97 (95% CI = 0.92 to 0.99); PPV would be 0.78 (95% CI = 0.46 to 0.94) and NPV 0.97 (95% CI = 0.92 to 0.99).
Conclusions: In neonates with LONS, sTREM-1 has the potential to provide an excellent predictive value
for septic shock/death. Larger sample sizes are needed to identify the optimal cut-off value of plasma
sTREM-1 for this diagnosis and to provide diagnostic accuracy measures.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/3.0/).
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license (http://creativecommons.org/licenses/by-nc-sa/3.0/).response by releasing cytokines, increasing cell surface receptors,
and activating neutrophil degranulation and oxidative burst.1,2 The
soluble fraction of sTREM-1 has been studied as a predictive tool
for sepsis, septic shock, and death in adults.3–7 The morbidity and
mortality rates of nosocomial or late-onset neonatal sepsis (LONS)
cases remain high, especially in preterm neonates.8–10 Until now,
the potential of sTREM-1 to speciﬁcally predict septic shock and
death in septic neonates has not been evaluated. Therefore, we
obtained estimates of the incidence of LONS and the prevalence of
septic shock for future sample size calculations and assessed the
feasibility of sTREM-1 as a predictor of these speciﬁc outcomes in
this population.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
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Figure 1. Legend: Patient ﬂow and eligibility chart. Center 1: Hospital Regional
Materno-Infantil, SSNL; Center 2: Hospital Metropolitano Dr. Bernardo Sepu´lveda,
SSNL. Patients recruited from May 1st to October 31, 2012. Patients with LONS
criteria included all gestational age and birth weight categories. Eligible patients
were those with LONS criteria and inclusion criteria. NICU = Newborn intensive care
unit; sTREM-1 = soluble fraction of triggering receptor expressed on myeloid cells-
1; LOD = Limit of detection; LONS = Late-onset neonatal sepsis.
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This study was conducted from May 1st to October 31st, 2012, in
two medical centers located in Northeastern Mexico: The Hospital
Regional Materno-Infantil (Center 1) and The Hospital Metropo-
litano Dr. Bernardo Sepu´lveda (Center 2). These two public
hospitals have level II-III neonatal intensive care units and belong
to the Servicios de Salud Network in Nuevo Leo´n, Mexico. The
inclusion criteria for this study population were as follows: inborn
neonates; suspicion of LONS, deﬁned as an infection occurring after
72 hours of life; a systemic inﬂammatory response syndrome
based on the criteria of the International Pediatric Sepsis
Consensus Conference and Haque10,11; and a nosocomial sepsis
predictive score (NOSEP-1) above 8 points. The NOSEP-1 is
determined based on C-reactive protein level, neutrophil fraction,
thrombocytopenia, fever, and prolonged parenteral nutrition. The
NOSEP-1 score provides a valuable tool for the early identiﬁcation
of nosocomial sepsis12,13 and has been validated in our popula-
tion.14 Because this was an exploratory study, a sequential, non-
probabilistic sampling method was employed, and no prior sample
size estimation was performed. Neonates born from mothers with
clinical chorioamnionitis, neonates born from HIV positive
mothers and neonates who had early-onset sepsis, congenital
infections, congenital anomalies, endocrine disorders, dehydra-
tion, asphyxia or birth trauma were excluded.
The study protocol was approved by the institutional human
research review boards at Escuela de Medicina, Tecnolo´gico de
Monterrey, and by the corresponding review boards at both study
hospitals, with the identiﬁer VPsTREMP/12/480. Eligible neonates
were included once clinical derangement attributed to LONS
occurred, and a written informed consent was obtained from their
parents or legal guardians. The data recorded included gestational
age, birth weight, gender, method of delivery, age at diagnosis of
LONS, age at development of main outcome, septic shock and
survival.
The included neonates were followed up for seven days after
inclusion to observe the appearance of septic shock and/or death.
Attributable mortality was deﬁned as death occurring within seven
days of inclusion in the study. The enrolled subjects were further
analyzed according to their progression to study outcomes, shock
and/or death (LONS & Shock/Death group), and those who did not
develop shock and survived (LONS-Non Shock group). All
participants, irrespective of the results of sTREM-1 determination,
were included in the analysis.
2.1. Biochemical measurements
The initial laboratory tests included a differential white blood
cell count and platelet count, measurement of the C-reactive
protein (CRP) level, blood culture and a sTREM-1 measurement in
plasma obtained from a blood sample. Plasma was separated from
blood and cryopreserved at -80 8C until analysis. Plasma sTREM-1
was quantiﬁed with the STREM Human ELISA kit (Cat. ab100659,
Abcam, USA) by a certiﬁed laboratory professional who was
blinded to the subject’s clinical status. The minimum limit of
detection (LOD) of sTREM-1 with this method was 20 pg/mL. The
results of the sTREM-1 measurement were not available to
attending clinicians; all samples were analyzed after study
recruitment was complete.
Septic shock was considered to have occurred when neonates
with LONS had hemodynamic deterioration deﬁned as tachycar-
dia (heart rate above 180 beats/min) and mean arterial blood
pressure < 30 mmHg in two consecutive measurements two
hours apart that required ﬂuid and inotropic therapy. The
diagnosis of septic shock also depended on two or more of the
following criteria: capillary reﬁll time > 4 seconds; oliguria, withdiuresis < 0.5 mL/h; and metabolic acidosis with a lactic acid level
above 2 mmol/L.10,11
Laboratory evidence of infection was a CRP >14 mg/L,
neutrophilia >50% and thrombocytopenia <150000. These pa-
rameters for the diagnosis of infection were similar to those
published elsewhere,8 although we also considered fever >38 8C
and total parenteral nutrition for 14 days, as are deﬁned in the
NOSEP-1 score.12,13
All data were de-identiﬁed, and participants were referred to
only by case numbers.
2.2. Statistical analysis
Data were not normally distributed, therefore non-parametric
statistical tools were used for the analysis. Values are expressed as
medians and interquartile ranges (IQR); categorical data are
expressed as frequencies and proportions. Mann-Whitney U, x2 or
Fisher’s exact tests were used for comparisons as appropriate.
Receiver operating characteristic curves (ROC) were constructed to
compare neonates affected or non-affected by septic shock.
Sensitivity, speciﬁcity, positive predictive value (PPV) and negative
predictive value (NPV) were calculated based on cutoff values
derived from the ROC analysis. Values with a p < 0.05 were
considered statistically signiﬁcant. The statistical analysis was
performed using IBM-SPSS Statistics 19 software (IBM Corporation,
Armonk, NY, USA).
3. Results
Over six months, a total of 11,629 live births occurred at the
study hospitals. The patient ﬂow and eligibility process are
depicted in Figure 1. Overall, 850 (7.3%) live neonates were
admitted to intensive care nurseries. Seventy-ﬁve of those
admissions met the established criteria of LONS and thus were
eligible for the study. From these, 71 were included. The
demographic characteristics of the entire study population are
shown in Table 1. The incidence of LONS during the study period
was 88 per 1000 NICU admissions (95% CI = 70 to 109). There were
slightly higher proportions of males and neonates born by cesarean
section. A majority of subjects had a gestational age equal to or
lower than 37 weeks and a birth weight below 2500 g. For the
71 subjects included in the study, the sTREM-1 values were below
LOD in 43 subjects (60.6%) and above LOD in the remaining
Table 1
Demographic characteristics of the study group, n = 71
Characteristic Value
Hospital a
Center 1 39 (55)




Method of delivery a
Vaginal 32 (45)
Abdominal 39 (55)
Gestational age, weeks.b 33 (30–37)
Birth weight, g.b 1750 (1076–2480)
Age at inclusion, days.b 10 (5–25)
NOSEP-1 score [refs 13–15].b 13 (9–14)
Legend: Center 1: Hospital Materno-Infantil de Alta Especiali-
dad, SSNL; Center 2: Hospital Metropolitano Dr. Bernardo
Sepu´lveda, SSNL;
a Frequency (%);
b Median (interquartile range). References 13–15 abound on
NOSEP-1 score.
Figure 2. Legend: Box and whisker plot of sTREM-1 concentrations (pg/mL) in the
LONS-Non-Shock (empty box) and the LONS & Shock/Death (vertical bars box)
groups.8 and * indicate atypical values. Mann-Whitney U test, p < 0.001.
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20 subjects in the LONS-Non Shock group and in 8 of 9 subjects in
the LONS & Shock/Death group.
Of the 71 enrolled neonates, nine (12.7%) progressed to septic
shock and/or death. Thus, in our study population, the septic shock
and/or death prevalence was 10.6 per 1000 NICU admissions (95%
CI = 4.9 to 20). In those subjects in whom septic shock developed, it
occurred within a median of 1.0 days (IQR = 1 to1.5) after study
inclusion. Five deaths occurred (7%); all of them were within two
days after study inclusion, and four of them were unequivocally
preceded by septic shock; thus, the mortality attributable to septic
shock was 4.7 per 1000 NICU admissions. Those who died did so at
a median of 1.5 days (IQR = 1.13 to 2.0) after study inclusion.
Considering all eligible subjects, death was strongly associated
with shock (p = 0.006). Subjects who developed shock had an odds
ratio for death of 23 (95% CI = 3 to 181). When considering onlyTable 2






n = 62 n = 9
Gender a
Male 33 (53) 4 (44)
Female 29 (47) 5 (56) NS c
Method of Delivery a
Vaginal 28 (45) 4 (44)
Abdominal 34 (55) 5 (56) NS c
Hospital a
Center 1 33 (53) 6 (67) NS c
Center 2 29 (47) 3 (33)
Blood culture a
Positive 23 (37) 3 (33)
Negative 39 (63) 6 (67) NS c
Gestational
age, Weeks b
34 (30–37) 30 (28–36) NS d
Birth weight, g b 1775 (1175–2483) 1260 (795–2680) NS d
Age at inclusion,
Days b
10.5 (5–28) 8 (5–9) NS d
NOSEP-1 score b 13 (9.8–14) 13 (8–13) NS d
sTREM-1, pg/mLb 10 (10–70) 567 (260–649) 0.001 d
Legend: LONS = Late-onset neonatal sepsis; LOD = Limit of Detection; NA = Not
applicable, since this category had only one subject; NS = Not signiﬁcant; Center 1:
Hospital Materno-Infantil de Alta Especialidad, SSNL; Center 2: Hospital
Metropolitano Dr. Bernardo Sepu´lveda, SSNL.
a Frequency (%);
b Median (interquartile range);
c Fisher’s exact test;
d Mann-Whitney’s U test.those subjects who progressed towards septic shock and were
positive for plasma sTREM-1, the association of shock with fatal
outcome remained signiﬁcant (p = 0.038), and the odds ratio for
death was 15 (95% CI = 1.22 to 181). As stated in the methods
section, all subjects, irrespective of the results of sTREM-1
determination below or above LOD, were included in the analysis
and the estimation of diagnostic accuracy. Data for the comparison
between groups are summarized and compared in Table 2.
In our study population, sTREM-1 had a median of 10 pg/mL
with an IQR = 10 to 95 pg/mL.
A greatly signiﬁcant difference for sTREM-1 values between the
LONS-Non Shock and LONS & Shock/Death groups was found
(p = 0.001) (Figure 2).
The ROC curve of the measured values of sTREM-1 as a predictor
of septic shock or death in this population yielded an area under
the curve of 0.884 (95% CI = 0.735 to1.0; p < 0.0001) (Fig. 3).
By examination of the coordinates of the ROC curve, we chose a
potential sTREM-1 cut-off value of 300 pg/mL, which would result
in the best relation of sensitivity to speciﬁcity. Since our goal was
to make a prediction of the outcome on neonates affected withFigure 3. Legend: Receiver operating characteristic (ROC) curve for sTREM-1 values
obtained from all participants, area under the ROC curve (AUC) 0.884 (95%
CI = 0.735 to 1.0), p < 0.0001.
Table 3
Frequency distribution of sTREM-1 results around the proposed cut-off value in
each outcome group, n = 71.
Outcome Group
Value of sTREM-1, pg/mL LONS-Non-Shocka LONS &Shock/Deatha
Above 300 2 (2.8) 7 (9.9)
Below 300 60 (84.5) 2 (2.8)
Legend: LONS = Late onset neonatal sepsis;
a Values are expressed as frequencies (percentage).
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instances the test yielded values below LOD, the real world
calculation of diagnostic accuracy should include all participants,
irrespective of the sTREM-1 result.
Doing so, and grouping them above and below the proposed
cut-off value, would yield the distribution shown in
Table 3. Therefore, from data of the whole study population, a
proposed sTREM-1 cut-off value of 300 pg/mL would exhibit a
sensitivity of 0.78 (95% CI = 0.46 to 0.94) and speciﬁcity of 0.97
(95% CI = 0.92 to 0.99); PPV would be 0.78 (95% CI = 0.46 to 0.94)
and NPV 0.97 (95% CI = 0.92 to 0.99).
No correlation was observed for sTREM-1 and gestational age;
birth weight; method of delivery; NOSEP-1 score; total leukocyte
number; proportion of neutrophils, eosinophils, basophils or
monocytes; platelet number or C-reactive protein level.
4. Discussion
In this study period, our cumulative incidence of LONS was
88 per 1000 newborn intensive care unit (NICU) admissions, which
was lower than the rate of 211 per 1000 VLBW neonate NICU
admissions reported by Stoll BJ et al. in 2002 and substantially
higher than the 6.3 episodes per 1000 admissions published by
Cohen-Wolkowiez et al. in 2009. Furthermore, our ﬁndings are
very similar to the 71/1000 NICU admissions reported by Vergnano
in 2011 and the 74 per 1000 preterm neonate NICU admissions
reported by Grisaru-Soen et al. from Israel in 2012.8,9,16–18
The variation in these reported rates may reﬂect differences in
study methodologies, LONS deﬁnitions or even actual differences
in the occurrence of these infections.
Our incidence of septic shock, 10.6/1000 NICU admissions, was
higher than the incidence of 2.2/1000 admissions reported by
Kermorvant-Duchemin et al.9 Although no data are available on
LONS and septic shock prevalence in underdeveloped countries,
such as ours, it is reasonable that similar results may be obtained
by future studies in underdeveloped countries.
In 2010, Saraﬁdis et al. published the results of their
prospective, observational study that aimed to compare the
diagnostic accuracy for LONS of sTREM-1 values to those of
interleukin-6. They selected 143 pg/mL of plasma sTREM-1 as the
best value for detecting infected neonates; however, sTREM-1 was
not found to be more accurate than IL-6 in differentiating infected
from non-infected neonates.10 Our study of a population of LONS
cases generated highly similar median and range values for plasma
sTREM-1, 140 (70 to 518) pg/mL, to those reported by Saraﬁdis
et al. A crucial difference between their work and ours is that we
aimed to identify the subset of LONS neonates who were prone to
an unfavorable outcome (shock or death). Mazzucchelli et al.
recently published their ﬁndings for a cohort of 71 neonates, 16 of
whom developed LONS and were compared to 16 non-infected
neonates. They obtained a sTREM-1 median value of 49.5 pg/mL
with an IQR of 13.5 to 176 pg/mL in infected neonates, which is
lower than our values. Mazzucchelli et al. advocate the use of the
CD64 index instead of sTREM-1, which in their series showed great
heterogeneity; nevertheless, they recognize that their sample sizewas small due to the nested case-control study design they
employed.19
Adly A.A. et al. reported much higher sTREM-1 values than
those of our study in a cohort of 112 infected neonates, but they
included patients with both early-onset and late-onset sepsis. In
their cohort, 75 participants can be identiﬁed as LONS, and in a
subset of 39 of these with culture-proven infection, they report a
mean  standard deviation of 1134.6  444 pg/mL. Overall, they
proposed a cut-off level of 310 pg/mL for sTREM-1, as a sensitive and
speciﬁc predictor of neonatal infection, which is in agreement with
our ﬁndings in the sickest patients. They found much higher values of
sTREM-1 in those individuals who died, 2053  889 pg/mL, than
those who survived and afﬁrmed that a sTREM-1 cutoff value of
1100 pg/mL is a good predictor of survival.20 The mean sTREM-1
values for the control subjects reported by their group were higher
than those reported by Saraﬁdis and our team for infected neonates
and were much higher than the results reported by Mazzucchelli
et al.10,19 Interestingly, we had undetectable levels of sTREM-1 in
roughly 61% of our subjects, even though all of them had strong
clinical indicators of infection. Neither Saraﬁdis, Mazzucchelli or Adly
reported how many subjects in their series had a sTREM-1 value
below LOD.10,19,20
We found that the infants who progressed to septic shock had
signiﬁcantly higher sTREM-1 levels than those with sepsis who did
not develop shock. Irrespective of different sTREM-1 values, which
could be the result of different study populations and the ELISA kits
used, previous works are in general agreement with our ﬁndings, in
the sense that sTREM-1 levels were higher in the sickest neonates,
and higher values are associated with poor prognosis.10,19,20 We
speculate that the possibility of sTREM-1 differences in relation to
genetic background should be explored in future trials.
In our population of neonates with LONS, our data clearly
suggest that a sTREM-1 value above 300 pg/mL accurately predicts
a progression to septic shock/death.
Garofoli et al., in a study of healthy neonates, established a
signiﬁcant negative correlation of sTREM-1 values and birth
weight.21 Similar results were reported for the membrane-bound
receptor by Matoba N et al. in neonates born preterm. Furthermore,
they proposed a potential correlation of inﬂammation with
preterm labor.22 Adly et al. also reported a signiﬁcant positive
sTREM-1 correlation with total leukocyte count, C-reactive protein
and sepsis score.20 In our study, we could not conﬁrm a signiﬁcant
positive or negative correlation of sTREM-1 with those variables,
perhaps because we were focused on the evaluation of sTREM-1 in
a group of neonates developing a complication of care (LONS) that
does not occur at birth, but rather occurs at least three days after
delivery. Instead, we observed that preterm neonates had a
statistically signiﬁcant lower median and interquartile range of
sTREM-1 values than term neonates (data not shown).
The attributable mortality in our study reached 7%, which is
greater than that reported by Grisaru-Soen in 2012 in a similar
population.18 The sickest newborns, those who had progressed to
septic shock, accounted for four of the ﬁve observed deaths in our
study.
The expression of TREM-1 by effector cells has been shown to be
dramatically increased in skin, biological ﬂuids and tissues infected
by Gram-positive and Gram-negative bacteria and fungi;2,5,7,23
however, in our study, 6 of 9 subjects with septic shock had
negative blood cultures, even though they had the highest sTREM-
1 values of the study population and progressed to septic shock.
Overall, 36.6% of the blood cultures in our series were positive.
In previous works in the same hospitals, we reported a blood
culture positivity rate in the vicinity of 42%.24 This lower rate of
blood culture positivity was likely due to the technical difﬁculties
in obtaining an adequate amount of blood for culture in smaller
neonates. Schelonka et al. (1996) and Kellogg et al. (1997)
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thirds of the cases of neonatal sepsis, and with the typical amount
of less than 4 to 10 bacterial CFU/mL in neonatal blood, volumes
lower than 1-1.5 mL should be considered inadequate for a
sensitive and timely detection of bacteremia.25,26 Because a
tendency toward lower birth weight was observed among this
group, although no statistically signiﬁcant difference was
achieved, we can speculate that a low-volume blood culture
sample may have been the cause of this ﬁnding. Furthermore, in
clinical practice it is not uncommon that blood volumes smaller
than ideal are sent for culture from smaller preterm babies, which
decreases the diagnostic yield of this important diagnostic tool.
Although blood culture is considered by many to be the gold
standard in the diagnosis of sepsis, its reported sensitivity ranges
from 40% to 86% and depends greatly on sample volume.11,24,25,27 It
is clear that patients affected by sepsis often do not have positive
cultures.
Nevertheless, it is accepted that deciding on purely clinical
grounds whether a patient is septic or not is inadequate; thus, we
must rely on all available diagnostic tools.12,28
Our inclusion criteria allowed us to exclude potential origins of
shock other than sepsis, such as cardiogenic, neurogenic, endo-
crine, hypovolemic and traumatic shock.
Our ﬁndings are in agreement with those of Gibot S. et al (2004),
who stated that in adults, a plasma sTREM-1 level higher than
60 pg/mL yields a sensitivity of 96%, speciﬁcity of 89%, positive
likelihood ratio (+LR) of 8.6 and negative likelihood ratio (–LR) of
0.04 for diagnosing patients with systemic inﬂammatory response
and sepsis.4 In a related paper published earlier the same year,
their group described a trend of higher sTREM-1 levels in subjects
who died than in survivors, and concluded that the detection of
sTREM-1 in bronchoalveolar lavage ﬂuid was useful for establish-
ing or excluding the diagnosis of bacterial or fungal pneumonia.3
In a meta-analysis developed to evaluate the accuracy of
sTREM-1 as a diagnostic test for bacterial infection, among
73 studies with adult populations, 13 were selected, with a total
of 980 patients included in the analysis. The median age was
60 years (IQR = 46 to 67 years), and the prevalence of bacterial
infections ranged from 34 to 80% across the studies. The meta-
analysis showed that sTREM-1 can be used as a helpful diagnostic
criterion for bacterial infection, except for urinary tract infections,
in adult populations. The importance of the negative likelihood
ratio is well supported, and it further reduces the post-test
probability, allowing researchers to rule out a possible infection.6
Zhang J. et al. also found that sTREM-1 levels accurately reﬂect the
severity of sepsis and are a sensitive prognostic tool.7
A deﬁnite weakness of our approach was our attempt to
establish sensitivity and speciﬁcity values using the same data-set
from which we obtained the proposed cut-off value of sTREM-1 as
a predictor of septic shock. When we derive a cut-off value from an
existing data-set, it is expected to perform well as a discriminator
in the same data-set.29 To validate our ﬁndings, future studies with
larger sample sizes and a prospective evaluation of a cut-off must
be performed to justify the derivation of important conclusions
using this diagnostic tool and to establish the best threshold value
of sTREM-1. Sensitivity, speciﬁcity and disease prevalence – and
therefore +LR and –LR – all interact to determine a test’s ability to
predict the presence or absence of any certain condition (disease or
outcome).29 It is necessary to continue studying the prognostic
potential of sTREM-1 as a predictor of septic shock in our setting.
Our next step is to perform an extended study to conﬁrm or
disprove our ﬁndings and to explore the predictive potential of
sTREM-1 in a larger cohort of neonates affected with LONS
with and without concomitant septic shock/death. Furthermore,
sTREM-1 should be compared to other biomarkers that have been
shown to be sensitive for the detection of severe sepsis and septicshock in adults, such as procalcitonin, soluble urokinase-type
plasminogen activator receptor and ST2, alone or as part of a panel
of biomarkers.30
5. Conclusion
In conclusion, sTREM-1 has the potential to provide excellent
predictive value. Further trials with larger sample sizes are needed
to identify the optimal cut-off value and to establish diagnostic
accuracy.
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